Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy
{{output}}
Metastasis-directed therapy (MDT) is an emerging treatment option for metachronous oligometastatic castration-sensitive prostate cancer (omCSPC) and can delay time to progression and the need to initiate androgen deprivation therapy (ADT). However, optimal way... ...
